病人选择和操作方法机械瓣vs生物瓣主动脉瓣替换西方观点（英文）.pptVIP

病人选择和操作方法:

机械瓣vs生物瓣主动脉瓣替换

西方观点;“Theidealprostheticvalvewouldhaveexcellenthemodynamics(similartoanormalhumanvalveinthesameposition),lastalifetime,befreeofstructuraldysfunctionorbreakdown,andrequirenoparticularmedicaltherapysuchasanticoagulation.Needlesstosay,suchavalveisyettobeavailable.”

;;推荐;;推荐;;前瞻性随机研究;0;100

80

60

40

20

0;100

80

60

40

20

0;100

80

60

40

20

0;100

80

60

40

20

0;100

80

60

40

20

0;生物瓣vs.机械瓣

AHA/ACC标准;年龄

主要的瓣膜选择标准;AHA/ACC指南;机械瓣风险;年龄vsINR

出血的时间;Davidetal.1996.;;生物瓣风险;Survival;竞争事件;结构毁损而取出;;瓣膜演变;16

14

12

10

8

6;Recommendations

ValveChoice;Clinical

RecommendationsTissueValve;临床建议-机械瓣;病人倾向性性

生活质量;Bioprostheses

Mechanical

Homograft;100

80

60

40

20

0;AVR人群 ;;;;PatientSelectionandPracticePatterns:

MechanicalvsBioprostheticAorticValves

PerspectiveWest;“Theidealprostheticvalvewouldhaveexcellenthemodynamics(similartoanormalhumanvalveinthesameposition),lastalifetime,befreeofstructuraldysfunctionorbreakdown,andrequirenoparticularmedicaltherapysuchasanticoagulation.Needlesstosay,suchavalveisyettobeavailable.”

;;Recommendations;;Recommendations;;ProspectiveRandomizedTrials;0;100

80

60

40

20

0;100

80

60

40

20

0;100

80

60

40

20

0;100

80

60

40

20

0;100

80

60

40

20

0;Tissuevs.Mechanical

AHA/ACCCriteria;Age

MajorCriteriaforValveSelection;BasisofAHA/ACCGuidelines;MechanicalValveRisk;AgevsINR

TimeofMajorBleeding;Davidetal.1996.;;BioprostheticValveRisk;Survival;CompetingEvents;ExplantforSVD;ValveReoperationsMortality;ProsthesisEvolution;16

14

12

10

8

6;Recommendations

ValveChoice;Clinical

RecommendationsTissueValve;Clinical

RecommendationsMechanicalValve;PatientPreference

QualityofLife;Bioprostheses

Mechanical

Homograft;100

80

60

40

20

0;AVRPopulation ;;